Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 196.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,570 shares of the company's stock after buying an additional 8,995 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Doximity were worth $787,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of the business. Fifth Third Bancorp increased its position in Doximity by 16.3% during the 1st quarter. Fifth Third Bancorp now owns 3,833 shares of the company's stock worth $222,000 after purchasing an additional 537 shares in the last quarter. Sarasin & Partners LLP acquired a new position in shares of Doximity during the first quarter worth $3,499,000. Handelsbanken Fonder AB increased its holdings in shares of Doximity by 14.8% during the first quarter. Handelsbanken Fonder AB now owns 34,100 shares of the company's stock worth $1,979,000 after buying an additional 4,400 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Doximity in the 1st quarter valued at $65,702,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Doximity by 62.3% during the 1st quarter. GAMMA Investing LLC now owns 2,816 shares of the company's stock valued at $163,000 after acquiring an additional 1,081 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.
Insider Transactions at Doximity
In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director owned 6,360 shares in the company, valued at approximately $381,600. This represents a 61.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer owned 357,165 shares of the company's stock, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 71,000 shares of company stock valued at $4,100,770. 37.40% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several equities analysts have commented on DOCS shares. Truist Financial dropped their target price on Doximity from $58.00 to $52.00 and set a "hold" rating for the company in a research report on Friday, May 16th. BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price on the stock in a research report on Monday, June 2nd. JPMorgan Chase & Co. reduced their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. KeyCorp dropped their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Finally, Bank of America lifted their price target on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Eleven analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $63.11.
Check Out Our Latest Report on DOCS
Doximity Stock Performance
Shares of Doximity stock traded up $2.38 on Friday, reaching $61.69. 1,058,376 shares of the company's stock were exchanged, compared to its average volume of 2,169,163. The company has a market capitalization of $11.59 billion, a P/E ratio of 61.69, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a 52 week low of $25.00 and a 52 week high of $85.21. The firm's 50-day moving average is $56.74 and its two-hundred day moving average is $58.95.
Doximity (NASDAQ:DOCS - Get Free Report) last released its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's quarterly revenue was up 17.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.25 EPS. On average, analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.